Fort Sheridan Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.8M | Sell |
4,869
-3
| -0.1% | -$2.34K | 0.54% | 40 |
|
|
2025
Q1 | $4.02M | Sell |
4,872
-18
| -0.4% | -$14.9K | 0.61% | 35 |
|
|
2024
Q4 | $3.77M | Buy |
4,890
+48
| +1% | +$37.1K | 0.55% | 36 |
|
|
2024
Q3 | $4.29M | Sell |
4,842
-26
| -0.5% | -$23K | 0.65% | 30 |
|
|
2024
Q2 | $4.41M | Sell |
4,868
-19
| -0.4% | -$17.2K | 0.71% | 28 |
|
|
2024
Q1 | $3.8M | Buy |
4,887
+3
| +0.1% | +$2.33K | 0.72% | 30 |
|
|
2023
Q4 | $2.85M | Sell |
4,884
-227
| -4% | -$132K | 0.57% | 34 |
|
|
2023
Q3 | $2.75M | Sell |
5,111
-80
| -2% | -$43K | 0.62% | 33 |
|
|
2023
Q2 | $2.43M | Buy |
5,191
+2,234
| +76% | +$1.05M | 0.56% | 34 |
|
|
2023
Q1 | $1.02M | Buy |
2,957
+867
| +41% | +$298K | 0.26% | 73 |
|
|
2022
Q4 | $765K | Sell |
2,090
-7
| -0.3% | -$2.56K | 0.25% | 75 |
|
|
2022
Q3 | $678K | Sell |
2,097
-201
| -9% | -$65K | 0.23% | 83 |
|
|
2022
Q2 | $745K | Buy |
2,298
+173
| +8% | +$56.1K | 0.24% | 76 |
|
|
2022
Q1 | $609K | Buy |
2,125
+33
| +2% | +$9.46K | 0.18% | 96 |
|
|
2021
Q4 | $578K | Buy |
2,092
+310
| +17% | +$85.7K | 0.17% | 100 |
|
|
2021
Q3 | $412K | Sell |
1,782
-27
| -1% | -$6.24K | 0.13% | 114 |
|
|
2021
Q2 | $415K | Sell |
1,809
-43
| -2% | -$9.87K | 0.14% | 110 |
|
|
2021
Q1 | $346K | Buy |
1,852
+150
| +9% | +$28K | 0.14% | 100 |
|
|
2020
Q4 | $287K | Sell |
1,702
-399
| -19% | -$67.3K | 0.14% | 98 |
|
|
2020
Q3 | $311K | Buy |
+2,101
| New | +$311K | 0.18% | 75 |
|